Filter
4860
Filtered Results: 4860
Text search:
Drug
list
Featured
Recommendations
459
New Publications
1303
Language
Document type
No document type
2882
Studies & Reports
692
Guidelines
684
Manuals
249
Strategic & Response Plan
157
Training Material
85
Fact sheets
68
Situation Updates
16
Resource Platforms
9
Brochures
8
Infographics
7
Online Courses
2
App
1
Countries / Regions
India
302
Global
156
Kenya
140
South Africa
130
Ethiopia
119
Uganda
110
Nigeria
105
Tanzania
85
Western and Central Europe
85
Nepal
83
Sierra Leone
81
Liberia
81
Malawi
75
Zambia
74
Latin America and the Carribbean
69
Bangladesh
68
Ghana
67
Africa
59
Myanmar / Burma
58
Rwanda
56
Namibia
53
Ukraine
42
Philippines
41
Zimbabwe
35
Eastern Europe
33
South–East Asia Region
32
Cambodia
31
Asia
31
Lesotho
26
Botswana
26
Indonesia
24
Congo, Democratic Republic of
23
Syria
22
Mozambique
21
Senegal
18
Brazil
18
Russia
18
Burkina Faso
17
Eswatini/ Swaziland
17
USA
15
Haiti
15
Germany
15
West and Central Africa
15
Cameroon
13
Middle East and North Africa
13
East and Southern Africa
13
Colombia
12
Eastern Europe and Central Asia
12
South Sudan
12
Thailand
10
Venezuela
10
Benin
9
Pakistan
9
Tajikistan
8
China
8
Albania
8
Paraguay
8
Vietnam
8
Georgia
8
Laos
7
Afghanistan
7
Guinea
7
Sudan
7
Western Pacific Region
6
Argentina
6
Madagascar
6
Chile
5
Peru
5
North America
5
Bolivia
5
Moldova
5
Sri Lanka
5
Mali
5
Iraq
5
North Macedonia
4
Timor Leste/ East Timor
4
Mexico
4
Iran
4
Jordan
4
Jamaica
4
Lebanon
4
Central African Republic
4
Angola
4
El Salvador
3
Fiji
3
Kyrgyzstan
3
Morocco
3
Armenia
3
Guinea-Bissau
3
United Kingdom
3
Papua New Guinea
3
Yemen
3
Libya
3
Somalia
3
Switzerland
2
Turkey
2
Kazakhstan
2
Canada
2
Uzbekistan
2
Mongolia
2
Hungary
2
Gabon
2
Uruguay
2
France
2
Tunisia
2
Spain
2
Southern Africa
2
Nicaragua
2
Palestine
2
Poland
2
Honduras
2
Bhutan
2
Guatemala
2
North Korea
1
Serbia
1
Australia
1
Gambia
1
Estonia
1
Congo-Brazzaville
1
Niger
1
Malaysia
1
Qatar
1
Bulgaria
1
Dominican Republic
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Norway
1
Portugal
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Belize
1
Costa Rica
1
Panama
1
Egypt
1
Romania
1
Greece
1
Chad
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1931
Clinical Guidelines
440
Public Health
219
Women & Child Health
201
Key Resources
150
Capacity Building
88
Pharmacy & Technologies
70
Annual Report MEDBOX
1
Toolboxes
Mental Health
480
HIV
461
TB
432
AMR
265
COVID-19
209
Pharmacy
185
NTDs
178
Caregiver
108
Rapid Response
96
NCDs
88
Malaria
81
Refugee
70
Ebola & Marburg
70
Conflict
62
Planetary Health
59
Disability
57
Global Health Education
47
Health Financing Toolbox
36
Specific Hazards
22
Polio
22
Natural Hazards
19
Social Ethics
16
Cholera
14
Zika
13
The portable diagnostic imaging technology covered by this document will serve not only the pressing demands for tuberculosis screening and triage but also other diseases. Therefore, the requirements, accessories, hardware and software packages listed in the following specifications are described in...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
The BBV/STI Glossary is a resource for interpreters, translators and others who work in a health setting. It offers an extensive list of English terms related to sexual health and blood-borne viruses (such as hepatitis), with easy to understand definitions.
Accessed 13th of November 2015.
Convention for the Protection of Human Rights and Fundamental Freedoms; Latest version from 2010.
For versions in French, Italian, German and Russian check:
http://www.cö.int/en/web/conventions/full-list/-/conventions/treaty/005?_cöconventions_WAR_cöconventionsportlet_languageId=en_GB
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
The Zithromax® Supply Chain Assessment Tool is designed to guide assessment team members through a series of interviews
with key informants and to establish inspection procedures when conducting logistics field assessments. The protocol allows
the assessment team to examine the readiness of the N...
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexuality; stigma and discrimination; gender discrimination...
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatment of chronic noncommunicable diseases. The evaluation combines both quantitative and qualitative anal...
Thematic brief. This brief highlights the link between climate change and VBDs in Asia Pacific. Using malaria to tell the narrative, it lists key actions that policymakers and the public health community can consider in addressing the impact of a changing climate on health. The brief also includes ...
The framework recommends expanded coverage of malaria diagnostic and treatment services, intensified vector control to drive down transmission, strengthened malaria surveillance, and increased transborder collaboration, especially in terms of efforts to control the sale and use of artemisinin monoth...
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
For biological agents, the publication covers 11 bacteria,
fungi and viruses listed by states parties to the Biological
Weapons Convention in declarations of past offensive
research and development programmes, or considered of
special concern for possible use in terrorism. All of these
agents c...
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retro...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
In the time of coronavirus disease (COVID-19), sex and drug use will continue, regardless of physical distancing orders and policies. People who previously met in community gathering venues such as bars and clubs may now meet in different sites, ones that are “hidden” or less accessible. This, i...
The Infection Prevention and Control (IPC) Legal Framework comes before the Specialized Technical Committee on Health and Drug Control for adoption and endorsement. The IPC Legal Framework is designed to guide Member States in the review and strengthening of laws and policies that support IPC at bot...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
